Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathogenicity of BALB/c-derived N-tropic murine leukemia viruses.
Pedersen L, Strauss PG, Schmidt J, Luz A, Erfle V, Jørgensen P, Kjeldgaard NO, Pedersen FS. Pedersen L, et al. Among authors: luz a. Virology. 1990 Dec;179(2):931-5. doi: 10.1016/0042-6822(90)90171-m. Virology. 1990. PMID: 2173270
Mapping of a major osteomagenic determinant of murine leukemia virus RFB-14 to non-long terminal repeat sequences.
Ostergaard M, Pedersen L, Schmidt J, Luz A, Lovmand J, Erfle V, Pedersen FS, Strauss PG. Ostergaard M, et al. Among authors: luz a. J Virol. 1997 Jan;71(1):645-9. doi: 10.1128/JVI.71.1.645-649.1997. J Virol. 1997. PMID: 8985395 Free PMC article.
Pedersen, W. Behnisch, J. Schmidt, A. Luz, F. S. Pedersen, V. Erfle, and P. G. Strauss, J. Virol. 66:6186-6190, 1992). ...Furthermore, we demonstrate that a strong determinant of leukemogenicity is harbored by the non-LTR region of SL3-3 MuLV....
Pedersen, W. Behnisch, J. Schmidt, A. Luz, F. S. Pedersen, V. Erfle, and P. G. Strauss, J. Virol. 66:6186-6190, 1992). ...Furt …
Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
Ethelberg S, Hallberg B, Lovmand J, Schmidt J, Luz A, Grundström T, Pedersen FS. Ethelberg S, et al. Among authors: luz a. J Virol. 1997 Feb;71(2):1196-206. doi: 10.1128/JVI.71.2.1196-1206.1997. J Virol. 1997. PMID: 8995642 Free PMC article.
SL3-3 is a highly T-lymphomagenic murine retrovirus. Previously, mutation of binding sites in the U3 repeat region for the AML1 transcription factor family (also known as core binding factor [CBF], polyomavirus enhancer binding protein 2 [PEBP2], and SL3-3 enhancer factor …
SL3-3 is a highly T-lymphomagenic murine retrovirus. Previously, mutation of binding sites in the U3 repeat region for the AML1 trans …
Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW, Sørensen AB, Bareil C, Schmidt J, Luz A, Pedersen FS. Amtoft HW, et al. Among authors: luz a. J Virol. 1997 Jul;71(7):5080-7. doi: 10.1128/JVI.71.7.5080-5087.1997. J Virol. 1997. PMID: 9188573 Free PMC article.
SL3-3 viruses with AML1 site mutations have lost a major determinant of T-cell-specific enhancer function but have been found to retain a lymphomagenic potential, although disease induction is slower than for the SL3-3 wild type. ...In some cases, however, including …
SL3-3 viruses with AML1 site mutations have lost a major determinant of T-cell-specific enhancer function but have been found to reta …
395 results